Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease.
D000328:Adult; D000368:Aged; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004809:Ephedrine / Q000008:administration & dosage; D005260:Female; D005541:Forced Expiratory Volume; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D006919:Hydroxyzine / Q000008:administration & dosage; D008168:Lung / Q000187:drug effects*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008450:Maximal Midexpiratory Flow Rate; D008875:Middle Aged; D010919:Placebos; D012129:Respiratory Function Tests; D013726:Terbutaline / Q000008:administration & dosage* / Q000494:pharmacology; D013806:Theophylline / Q000008:administration & dosage; D014797:Vital Capacity / Q000187:drug effects
D001993:Bronchodilator Agents; D004338:Drug Combinations; D010919:Placebos; D006919:Hydroxyzine; D013806:Theophylline; D004809:Ephedrine; D013726:Terbutaline